BEAM
Price
$24.31
Change
-$1.39 (-5.41%)
Updated
Apr 17, 6:59 PM EST
20 days until earnings call
NVAX
Price
$3.89
Change
-$0.10 (-2.51%)
Updated
Apr 17, 6:59 PM EST
20 days until earnings call
Ad is loading...

Compare predictions BEAM vs NVAX

Header iconBEAM vs NVAX Comparison
Open Charts BEAM vs NVAXBanner chart's image
Beam Therapeutics
Price$24.31
Change-$1.39 (-5.41%)
Volume$665.49K
CapitalizationN/A
Novavax
Price$3.89
Change-$0.10 (-2.51%)
Volume$2.43M
CapitalizationN/A
View a ticker or compare two or three
BEAM vs NVAX Comparison Chart

Loading...

BEAMDaily Signal changed days agoGain/Loss if shorted
 
Show more...
NVAXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
BEAM vs. NVAX commentary
Apr 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and NVAX is a Hold.

COMPARISON
Comparison
Apr 18, 2024
Stock price -- (BEAM: $25.70 vs. NVAX: $3.99)
Brand notoriety: BEAM: Not notable vs. NVAX: Notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 110% vs. NVAX: 48%
Market capitalization -- BEAM: $2.1B vs. NVAX: $558.41M
BEAM [@Biotechnology] is valued at $2.1B. NVAX’s [@Biotechnology] market capitalization is $558.41M. The market cap for tickers in the [@Biotechnology] industry ranges from $559.84B to $0. The average market capitalization across the [@Biotechnology] industry is $2.54B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whileNVAX’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • NVAX’s FA Score: 0 green, 5 red.
According to our system of comparison, BEAM is a better buy in the long-term than NVAX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 3 TA indicator(s) are bullish while NVAX’s TA Score has 2 bullish TA indicator(s).

  • BEAM’s TA Score: 3 bullish, 5 bearish.
  • NVAX’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than NVAX.

Price Growth

BEAM (@Biotechnology) experienced а -12.35% price change this week, while NVAX (@Biotechnology) price change was -9.73% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -5.56%. For the same industry, the average monthly price growth was -0.06%, and the average quarterly price growth was +1233.13%.

Reported Earning Dates

BEAM is expected to report earnings on Aug 06, 2024.

NVAX is expected to report earnings on Aug 06, 2024.

Industries' Descriptions

@Biotechnology (-5.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for BEAM with price predictions.
OPEN
A.I.dvisor published
a Summary for NVAX with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
BEAM($2.1B) has a higher market cap than NVAX($558M). BEAM YTD gains are higher at: -5.584 vs. NVAX (-16.875).
BEAMNVAXBEAM / NVAX
Capitalization2.1B558M376%
EBITDAN/AN/A-
Gain YTD-5.584-16.87533%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
NVAX: Fundamental Ratings
NVAX
OUTLOOK RATING
1..100
52
VALUATION
overvalued / fair valued / undervalued
1..100
87
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
98
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMNVAX
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
83%
Stochastic
ODDS (%)
N/A
Bullish Trend 2 days ago
80%
Momentum
ODDS (%)
Bearish Trend 6 days ago
84%
Bearish Trend 2 days ago
87%
MACD
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 28 days ago
81%
N/A
Declines
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
87%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Ad is loading...
BEAMDaily Signal changed days agoGain/Loss if shorted
 
Show more...
NVAXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MSFAX34.12N/A
N/A
Morgan Stanley Inst Global Franchise I
GGIPX22.08-0.05
-0.23%
Goldman Sachs GQG Ptnrs Intl Opps P
MAAKX22.39-0.06
-0.27%
MoA All America Fund
TESGX8.53-0.05
-0.58%
Templeton Global Smaller Comp C
SJVIX26.52-0.16
-0.60%
Steward Large Cap Value I